Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- What are some of the most common concerns or questions newly diagnosed CML patients may have about their initial treatment plan?
- What are some common adverse effects or tolerability challenges patients may experience with their initial treatment plan?
- What is your best practice to set clear expectations with your patients on what they may experience along their CML journey?
Recent Videos
Related Content
Pirtobrutinib May Provide Benefit in Treatment Sequencing of Relapsed/Refractory CLL/SLL
December 12th 2024Article
Treatment with pirtobrutinib induced superior progression-free survival among heavily pretreated patients with relapsed or refractory CLL/SS previously treated with a covalent BTK inhibitor.
